{"transactions":[{"id":4636986,"issuer":{"id":1170,"kind":"organization","name":"ACCURAY INC","symbol":"ARAY"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-10-07T20:10:08.000Z","date":"2026-10-05","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This represents a Non-Qualified Stock Option that will vest in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":75000,"derivative":{"exercise_price":0.3,"expiration_date":"2033-10-05","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001214659-26-012649","document":"marketforms-74110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1227305/000121465926012649/marketforms-74110.xml","form_type":"4"}},{"id":4636985,"issuer":{"id":1170,"kind":"organization","name":"ACCURAY INC","symbol":"ARAY"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-10-07T20:10:08.000Z","date":"2026-10-05","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This represents a Restricted Stock Unit that vests in three equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This represents a Restricted Stock Unit that vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":75000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001214659-26-012649","document":"marketforms-74110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1227305/000121465926012649/marketforms-74110.xml","form_type":"4"}},{"id":905772,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-14T00:00:05.000Z","date":"2025-12-30","kind":"gift","planned":false,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":126926,"source":{"system":"sec-edgar","filing":"0001628280-26-008241","document":"wk-form5_1771027202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026008241/wk-form5_1771027202.xml","form_type":"5"}},{"id":1137827,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T21:00:00.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":6650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 20, 2025. Price not applicable."}],"balance_after":127426,"source":{"system":"sec-edgar","filing":"0001048477-25-000076","document":"wk-form4_1747947594.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000076/wk-form4_1747947594.xml","form_type":"4"}},{"id":1493194,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-06-04T23:28:12.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":false,"shares":6600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":63.1,"exercise_date":"2014-09-04","expiration_date":"2024-06-03","underlying":"Common Stock","underlying_shares":6600},"source":{"system":"sec-edgar","filing":"0001048477-24-000116","document":"wk-form4_1717543684.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000116/wk-form4_1717543684.xml","form_type":"4"}},{"id":1493193,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T23:28:12.000Z","date":"2024-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":5451,"price":76.41,"value":416510.91,"ownership":{"direct":true},"balance_after":120776,"source":{"system":"sec-edgar","filing":"0001048477-24-000116","document":"wk-form4_1717543684.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000116/wk-form4_1717543684.xml","form_type":"4"}},{"id":1493192,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T23:28:12.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":true,"shares":6600,"price":63.1,"value":416460.0,"ownership":{"direct":true},"balance_after":126227,"source":{"system":"sec-edgar","filing":"0001048477-24-000116","document":"wk-form4_1717543684.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000116/wk-form4_1717543684.xml","form_type":"4"}},{"id":1504169,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-23T21:34:53.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":7080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 21, 2024. Price not applicable."}],"balance_after":119627,"source":{"system":"sec-edgar","filing":"0001048477-24-000108","document":"wk-form4_1716500073.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000108/wk-form4_1716500073.xml","form_type":"4"}},{"id":1673428,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-24T00:47:11.000Z","date":"2024-01-08","kind":"gift","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":112547,"source":{"system":"sec-edgar","filing":"0001048477-24-000004","document":"wk-form4_1706057221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000004/wk-form4_1706057221.xml","form_type":"4"}},{"id":1880119,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-24T22:27:48.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":4190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 23, 2023. Price not applicable."}],"balance_after":115547,"source":{"system":"sec-edgar","filing":"0001209191-23-031975","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123031975/doc4.xml","form_type":"4"}},{"id":1889785,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2023-05-17T22:14:59.000Z","date":"2023-05-12","kind":"exercise","planned":false,"acquired":false,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":67.81,"exercise_date":"2013-08-15","expiration_date":"2023-05-14","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001209191-23-030368","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123030368/doc4.xml","form_type":"4"}},{"id":1889784,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-17T22:14:59.000Z","date":"2023-05-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":6137,"price":93.93,"value":576448.41,"ownership":{"direct":true},"balance_after":111357,"source":{"system":"sec-edgar","filing":"0001209191-23-030368","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123030368/doc4.xml","form_type":"4"}},{"id":1889783,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-17T22:14:59.000Z","date":"2023-05-12","kind":"exercise","planned":false,"acquired":true,"shares":8500,"price":67.81,"value":576385.0,"ownership":{"direct":true},"balance_after":117494,"source":{"system":"sec-edgar","filing":"0001209191-23-030368","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123030368/doc4.xml","form_type":"4"}},{"id":2133625,"issuer":{"id":122956,"kind":"organization","name":"Rockley Photonics Holdings Ltd","symbol":"RKLY"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Stock Option (right to buy)","published_at":"2022-10-21T17:43:39.000Z","date":"2022-10-21","kind":"grant","acquired":true,"shares":1891521,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option will vest over 4 years, with 25% vesting on the first anniversary of the date of grant, and the remaining 75% vesting in quarterly installments over the remaining 3 years, subject to continued service and acceleration upon a change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Stock Option will vest over 4 years, with 25% vesting on the first anniversary of the date of grant, and the remaining 75% vesting in quarterly installments over the remaining 3 years, subject to continued service and acceleration upon a change in control."}],"balance_after":1891521,"derivative":{"exercise_price":0.63,"underlying":"Ordinary Share","underlying_shares":1891521},"source":{"system":"sec-edgar","filing":"0001852117-22-000396","document":"wf-form4_166638860535626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1852117/000185211722000396/wf-form4_166638860535626.xml","form_type":"4"}},{"id":2133624,"issuer":{"id":122956,"kind":"organization","name":"Rockley Photonics Holdings Ltd","symbol":"RKLY"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Restricted Stock Unit","published_at":"2022-10-21T17:43:39.000Z","date":"2022-10-21","kind":"grant","acquired":true,"shares":1891521,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The RSU will vest over 4 years, with 25% vesting on the first anniversary of the date of grant, and the remaining 75% vesting in quarterly installments over the remaining 3 years, subject to continued service and acceleration upon a change in control."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The RSU will vest over 4 years, with 25% vesting on the first anniversary of the date of grant, and the remaining 75% vesting in quarterly installments over the remaining 3 years, subject to continued service and acceleration upon a change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The RSU will vest over 4 years, with 25% vesting on the first anniversary of the date of grant, and the remaining 75% vesting in quarterly installments over the remaining 3 years, subject to continued service and acceleration upon a change in control."}],"balance_after":1891521,"derivative":{"underlying":"Ordinary Share","underlying_shares":1891521},"source":{"system":"sec-edgar","filing":"0001852117-22-000396","document":"wf-form4_166638860535626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852117/000185211722000396/wf-form4_166638860535626.xml","form_type":"4"}},{"id":2255596,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T01:24:03.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":4980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 24, 2022.  Price not applicable."}],"balance_after":108994,"source":{"system":"sec-edgar","filing":"0001567619-22-011798","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922011798/doc1.xml","form_type":"4"}},{"id":2270074,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2022-05-16T18:43:33.000Z","date":"2022-05-13","kind":"other","acquired":false,"shares":74852,"price":28.25,"value":2114569.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."}],"balance_after":0,"derivative":{"exercise_price":21.6,"expiration_date":"2029-11-26","underlying":"Common Stock","underlying_shares":74852},"source":{"system":"sec-edgar","filing":"0001562180-22-004076","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218022004076/primarydocument.xml","form_type":"4"}},{"id":2270073,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2022-05-16T18:43:33.000Z","date":"2022-05-13","kind":"other","acquired":false,"shares":34000,"price":28.25,"value":960500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."}],"balance_after":0,"derivative":{"exercise_price":23.07,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001562180-22-004076","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218022004076/primarydocument.xml","form_type":"4"}},{"id":2270072,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-16T18:43:33.000Z","date":"2022-05-13","kind":"other","acquired":false,"shares":40607,"price":28.25,"value":1147147.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger (the 'Merger Agreement'), dated August 6, 2021, by and among the Issuer, Medtronic, Inc. ('Parent') and Project Kraken Merger Sub, Inc., a wholly-owned subsidiary of Parent ('Merger Sub'), including the consummation of the merger (the 'Merger') between Issuer and Merger Sub on May 13, 2022. Pursuant to the Merger Agreement, as of the effective time of the Merger (the 'Effective Time'), [each outstanding share of Issuer common stock, $0.001 par value per share ('Issuer Common Stock'), was cancelled, retired and converted into the right to receive an amount equal to $28.25 in cash, without interest thereon (the 'Common Stock Merger Consideration'), subject to any required withholding of taxes]."},{"field":"shares","element":"transactionShares","label":"F4","text":"Includes 4,400 shares at the children's trust."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger (the 'Merger Agreement'), dated August 6, 2021, by and among the Issuer, Medtronic, Inc. ('Parent') and Project Kraken Merger Sub, Inc., a wholly-owned subsidiary of Parent ('Merger Sub'), including the consummation of the merger (the 'Merger') between Issuer and Merger Sub on May 13, 2022. Pursuant to the Merger Agreement, as of the effective time of the Merger (the 'Effective Time'), [each outstanding share of Issuer common stock, $0.001 par value per share ('Issuer Common Stock'), was cancelled, retired and converted into the right to receive an amount equal to $28.25 in cash, without interest thereon (the 'Common Stock Merger Consideration'), subject to any required withholding of taxes]."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-22-004076","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218022004076/primarydocument.xml","form_type":"4"}},{"id":2270071,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-16T18:43:33.000Z","date":"2022-05-13","kind":"other","acquired":false,"shares":65759,"price":28.25,"value":1857691.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit that was subject to vesting conditions based solely on continued employment with or service to the Company or any of its subsidiaries (each, an 'Issuer RSU') that was outstanding and unvested immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer RSU and (2) the Common Stock Merger Consideration, subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit that was subject to vesting conditions based solely on continued employment with or service to the Company or any of its subsidiaries (each, an 'Issuer RSU') that was outstanding and unvested immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer RSU and (2) the Common Stock Merger Consideration, subject to any required withholding of taxes."}],"balance_after":40607,"source":{"system":"sec-edgar","filing":"0001562180-22-004076","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218022004076/primarydocument.xml","form_type":"4"}},{"id":2270070,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-16T18:43:33.000Z","date":"2022-05-13","kind":"other","acquired":false,"shares":57230,"price":28.25,"value":1616747.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit that was subject to performance-based vesting conditions (each, an 'Issuer PSU') that was outstanding and became vested prior to or upon the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer PSU and (2) the Common Stock Merger Consideration, subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit that was subject to performance-based vesting conditions (each, an 'Issuer PSU') that was outstanding and became vested prior to or upon the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer PSU and (2) the Common Stock Merger Consideration, subject to any required withholding of taxes."}],"balance_after":106366,"source":{"system":"sec-edgar","filing":"0001562180-22-004076","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218022004076/primarydocument.xml","form_type":"4"}},{"id":2282719,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2022-05-04T16:21:04.000Z","date":"2022-05-02","kind":"exercise","acquired":false,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":37.46,"exercise_date":"2012-11-08","expiration_date":"2022-05-07","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001567619-22-009496","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922009496/doc1.xml","form_type":"4"}},{"id":2282718,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-04T16:21:04.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":18,"price":82.115,"value":1478.07,"ownership":{"direct":true},"balance_after":104014,"source":{"system":"sec-edgar","filing":"0001567619-22-009496","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922009496/doc1.xml","form_type":"4"}},{"id":2282717,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-04T16:21:04.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":3860,"price":82.09,"value":316867.4,"ownership":{"direct":true},"balance_after":104032,"source":{"system":"sec-edgar","filing":"0001567619-22-009496","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922009496/doc1.xml","form_type":"4"}},{"id":2282716,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-04T16:21:04.000Z","date":"2022-05-02","kind":"exercise","acquired":true,"shares":8500,"price":37.46,"value":318410.0,"ownership":{"direct":true},"balance_after":107892,"source":{"system":"sec-edgar","filing":"0001567619-22-009496","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922009496/doc1.xml","form_type":"4"}},{"id":2411535,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-04T21:06:30.000Z","date":"2022-02-02","kind":"tax_withholding","acquired":false,"shares":2329,"price":27.3064,"value":63596.6056,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares tendered in payment of the tax withholding obligation in compliance and as required by the company's equity documents."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $27.20 to $27.55, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 122,989 restricted stock units, of which 57,230 are performance based."}],"balance_after":163596,"source":{"system":"sec-edgar","filing":"0001562180-22-001159","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218022001159/primarydocument.xml","form_type":"4"}},{"id":2411534,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-04T21:06:30.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":36738,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in three equal annual installments commencing one year after the Vesting Commencement Date of February 1, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 128,793 restricted stock units, of which 57,230 are performance based."}],"balance_after":165925,"source":{"system":"sec-edgar","filing":"0001562180-22-001159","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218022001159/primarydocument.xml","form_type":"4"}},{"id":2490390,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-01T18:07:31.000Z","date":"2021-11-29","kind":"tax_withholding","acquired":false,"shares":6346,"price":26.9388,"value":170953.6248,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares tendered in payment of the tax withholding obligation in compliance and as required by the company's equity documents."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $26.85 to $27.02, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 92,055 restricted stock units, of which 57,230 are performance based."}],"balance_after":129187,"source":{"system":"sec-edgar","filing":"0001562180-21-007368","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218021007368/primarydocument.xml","form_type":"4"}},{"id":2693923,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T23:29:38.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":5120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 25, 2021.  Price not applicable."}],"balance_after":99392,"source":{"system":"sec-edgar","filing":"0001567619-21-011316","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921011316/doc1.xml","form_type":"4"}},{"id":2723616,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2021-05-07T23:48:28.000Z","date":"2021-05-06","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":26.49,"exercise_date":"2011-11-12","expiration_date":"2021-05-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-21-009351","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921009351/doc1.xml","form_type":"4"}},{"id":2723615,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-07T23:48:28.000Z","date":"2021-05-06","kind":"sale","acquired":false,"shares":5068,"price":78.383,"value":397245.044,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is the weighted average price.  The price actually received ranged from $78.38 to $78.405.  The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price."}],"balance_after":94272,"source":{"system":"sec-edgar","filing":"0001567619-21-009351","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921009351/doc1.xml","form_type":"4"}},{"id":2723614,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-07T23:48:28.000Z","date":"2021-05-06","kind":"exercise","acquired":true,"shares":15000,"price":26.49,"value":397350.0,"ownership":{"direct":true},"balance_after":99340,"source":{"system":"sec-edgar","filing":"0001567619-21-009351","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921009351/doc1.xml","form_type":"4"}},{"id":2881302,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2021-02-03T20:35:15.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting commencement date of the option is February 1, 2021.  1/8th of the shares subject to the option shall vest on August 1, 2021 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months."}],"balance_after":34000,"derivative":{"exercise_price":23.07,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001562180-21-000884","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218021000884/primarydocument.xml","form_type":"4"}},{"id":2881301,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-03T20:35:15.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":17411,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in three equal annual installments commencing one year after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 109,468 restricted stock units, of which 57,230 are performance based."}],"balance_after":135533,"source":{"system":"sec-edgar","filing":"0001562180-21-000884","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218021000884/primarydocument.xml","form_type":"4"}},{"id":2962569,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-01T17:23:34.000Z","date":"2020-11-27","kind":"tax_withholding","acquired":false,"shares":6349,"price":20.0036,"value":127002.8564,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares tendered in payment of the tax withholding obligation in compliance and as required by the company's equity documents."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $19.72 to $20.29, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 92,057 restricted stock units, of which 57,230 are performance based."}],"balance_after":118122,"source":{"system":"sec-edgar","filing":"0001562180-20-006990","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218020006990/primarydocument.xml","form_type":"4"}},{"id":3131041,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-29T22:07:36.000Z","date":"2020-05-27","kind":"grant","acquired":true,"shares":4300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 27, 2020. Price not applicable."}],"balance_after":84340,"source":{"system":"sec-edgar","filing":"0001567619-20-011364","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920011364/doc1.xml","form_type":"4"}},{"id":3204738,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-17T20:37:02.000Z","date":"2020-03-17","kind":"purchase","acquired":true,"shares":5000,"price":7.7994,"value":38997.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 109,471 restricted stock units, of which 57,230 are performance based."}],"balance_after":124471,"source":{"system":"sec-edgar","filing":"0001562180-20-002595","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218020002595/primarydocument.xml","form_type":"4"}},{"id":3204736,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-17T06:02:21.000Z","date":"2020-03-16","kind":"purchase","acquired":true,"shares":2500,"price":13.75,"value":34375.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 109,471 restricted stock units, of which 57,230 are performance based."}],"balance_after":119471,"source":{"system":"sec-edgar","filing":"0001562180-20-002562","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218020002562/primarydocument.xml","form_type":"4"}},{"id":3204735,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-17T06:02:21.000Z","date":"2020-03-16","kind":"purchase","acquired":true,"shares":2500,"price":13.5,"value":33750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 109,471 restricted stock units, of which 57,230 are performance based."}],"balance_after":116971,"source":{"system":"sec-edgar","filing":"0001562180-20-002562","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218020002562/primarydocument.xml","form_type":"4"}},{"id":3204734,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-17T06:02:21.000Z","date":"2020-03-16","kind":"purchase","acquired":true,"shares":2500,"price":12.75,"value":31875.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 109,471 restricted stock units, of which 57,230 are performance based."}],"balance_after":114471,"source":{"system":"sec-edgar","filing":"0001562180-20-002562","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218020002562/primarydocument.xml","form_type":"4"}},{"id":3204733,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-17T06:02:21.000Z","date":"2020-03-16","kind":"purchase","acquired":true,"shares":2500,"price":10.185,"value":25462.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 109,471 restricted stock units, of which 57,230 are performance based."}],"balance_after":111971,"source":{"system":"sec-edgar","filing":"0001562180-20-002562","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218020002562/primarydocument.xml","form_type":"4"}},{"id":3356662,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2019-11-29T13:44:47.000Z","date":"2019-11-26","kind":"grant","acquired":true,"shares":74852,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The vesting commencement date of the option is November 26, 2019.  1/4th of the shares subject to the option shall vest on November 26, 2020 and 1/48th of the shares subject to the option shall vest monthly thereafter over 36 months."}],"balance_after":74852,"derivative":{"exercise_price":21.6,"expiration_date":"2029-11-26","underlying":"Common Stock","underlying_shares":74852},"source":{"system":"sec-edgar","filing":"0001562180-19-005773","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019005773/primarydocument.xml","form_type":"4"}},{"id":3356661,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-29T13:44:47.000Z","date":"2019-11-26","kind":"grant","acquired":true,"shares":57230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units shall vest on the third anniversary from the date of grant provided that certain 30-day trailing average stock price (the \"Average Closing Price\") targets are achieved at any time during the three year period following the date of grant. 33 1/3%, 66 2/3% or 100% of the shares will vest if the Average Closing Price equals or exceeds specific stock price targets."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Restricted stock units, of which 57,230 are performance based."}],"balance_after":109471,"source":{"system":"sec-edgar","filing":"0001562180-19-005773","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019005773/primarydocument.xml","form_type":"4"}},{"id":3356660,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-29T13:44:47.000Z","date":"2019-11-26","kind":"grant","acquired":true,"shares":52241,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in three equal annual installments commencing one year after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Restricted stock units."}],"balance_after":52241,"source":{"system":"sec-edgar","filing":"0001562180-19-005773","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019005773/primarydocument.xml","form_type":"4"}},{"id":3462987,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-12T23:09:48.000Z","date":"2019-06-11","kind":"gift","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction involved gifts of securities by the reporting person to irrevocable trusts for the benefit of the reporting person's children and for which the reporting person is not the trustee. The reporting person disclaims beneficial ownership of the shares held by such irrevocable trusts, and this report should not be deemed an admission that the reporting person is the beneficial owner of such shares."}],"balance_after":80040,"source":{"system":"sec-edgar","filing":"0001567619-19-014738","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919014738/doc1.xml","form_type":"4"}},{"id":3499218,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-06T22:17:32.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":4430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 4, 2019 . Price not applicable."}],"balance_after":86040,"source":{"system":"sec-edgar","filing":"0001567619-19-012978","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919012978/doc1.xml","form_type":"4"}},{"id":3814681,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2018-09-17T23:22:24.000Z","date":"2018-09-13","kind":"exercise","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":21.51,"exercise_date":"2010-11-12","expiration_date":"2020-05-11","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001567619-18-002765","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918002765/doc1.xml","form_type":"4"}},{"id":3814680,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2018-09-17T23:22:24.000Z","date":"2018-09-13","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":12000,"derivative":{"exercise_price":21.51,"exercise_date":"2010-11-12","expiration_date":"2020-05-11","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001567619-18-002765","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918002765/doc1.xml","form_type":"4"}},{"id":3814679,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-17T23:22:24.000Z","date":"2018-09-13","kind":"sale","acquired":false,"shares":200,"price":99.25,"value":19850.0,"ownership":{"direct":true},"balance_after":81610,"source":{"system":"sec-edgar","filing":"0001567619-18-002765","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918002765/doc1.xml","form_type":"4"}},{"id":3814678,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-17T23:22:24.000Z","date":"2018-09-13","kind":"sale","acquired":false,"shares":2800,"price":99.24,"value":277872.0,"ownership":{"direct":true},"balance_after":81810,"source":{"system":"sec-edgar","filing":"0001567619-18-002765","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918002765/doc1.xml","form_type":"4"}},{"id":3814677,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-17T23:22:24.000Z","date":"2018-09-13","kind":"exercise","acquired":true,"shares":3000,"price":21.51,"value":64530.0,"ownership":{"direct":true},"balance_after":84610,"source":{"system":"sec-edgar","filing":"0001567619-18-002765","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918002765/doc1.xml","form_type":"4"}},{"id":3814676,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-17T23:22:24.000Z","date":"2018-09-13","kind":"exercise","acquired":true,"shares":12000,"price":21.51,"value":258120.0,"ownership":{"direct":true},"balance_after":81610,"source":{"system":"sec-edgar","filing":"0001567619-18-002765","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918002765/doc1.xml","form_type":"4"}},{"id":3830778,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2018-08-29T19:51:44.000Z","date":"2018-08-27","kind":"exercise","acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":14.39,"exercise_date":"2009-11-12","expiration_date":"2019-05-11","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001567619-18-001878","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918001878/doc1.xml","form_type":"4"}},{"id":3830777,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2018-08-29T19:51:44.000Z","date":"2018-08-27","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":13000,"derivative":{"exercise_price":14.39,"exercise_date":"2009-11-12","expiration_date":"2019-05-11","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001567619-18-001878","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918001878/doc1.xml","form_type":"4"}},{"id":3830776,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-29T19:51:44.000Z","date":"2018-08-27","kind":"sale","acquired":false,"shares":2000,"price":100.1177,"value":200235.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is the weighted average price.  The price actually received ranged from $100.112 to $100.130.  The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price."}],"balance_after":69610,"source":{"system":"sec-edgar","filing":"0001567619-18-001878","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918001878/doc1.xml","form_type":"4"}},{"id":3830775,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-29T19:51:44.000Z","date":"2018-08-27","kind":"exercise","acquired":true,"shares":2000,"price":14.39,"value":28780.0,"ownership":{"direct":true},"balance_after":71610,"source":{"system":"sec-edgar","filing":"0001567619-18-001878","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918001878/doc1.xml","form_type":"4"}},{"id":3830774,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-29T19:51:44.000Z","date":"2018-08-27","kind":"exercise","acquired":true,"shares":13000,"price":14.39,"value":187070.0,"ownership":{"direct":true},"balance_after":69610,"source":{"system":"sec-edgar","filing":"0001567619-18-001878","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918001878/doc1.xml","form_type":"4"}},{"id":3902160,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T00:55:16.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":4300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 5, 2018. Price not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of securities beneficially owned has been updated from the reporting person's prior report to include 1,000 shares inadvertently omitted from prior reports based on a reconciliation with the Company's records."}],"balance_after":56610,"source":{"system":"sec-edgar","filing":"0001140361-18-027795","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036118027795/doc1.xml","form_type":"4"}},{"id":3926227,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy) Common Stock","published_at":"2018-05-18T22:33:49.000Z","date":"2018-05-17","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":38.59,"exercise_date":"2008-11-22","expiration_date":"2018-05-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-18-024760","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036118024760/doc1.xml","form_type":"4"}},{"id":3926226,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-18T22:33:49.000Z","date":"2018-05-17","kind":"exercise","acquired":true,"shares":15000,"price":38.59,"value":578850.0,"ownership":{"direct":true},"balance_after":51310,"source":{"system":"sec-edgar","filing":"0001140361-18-024760","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036118024760/doc1.xml","form_type":"4"}},{"id":4067714,"issuer":{"id":6858,"kind":"organization","name":"ACCENDRA HEALTH INC/VA/","symbol":"ACH"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-02-12T21:22:07.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":22013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted stock with three year vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes employee stock purchase plan holdings and/or shares acquired through dividend reinvestment transactions not previously reflected in beneficial ownership total."}],"balance_after":127158,"source":{"system":"sec-edgar","filing":"0000075252-18-000030","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/75252/000007525218000030/edgar.xml","form_type":"4"}},{"id":4288767,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy) Common Stock","published_at":"2017-06-08T22:21:51.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":4910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests in full on June 6, 2018."}],"balance_after":4910,"derivative":{"exercise_price":89.6,"exercise_date":"2018-06-06","expiration_date":"2027-06-05","underlying":"Common Stock","underlying_shares":4910},"source":{"system":"sec-edgar","filing":"0001140361-17-024502","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036117024502/doc1.xml","form_type":"4"}},{"id":4288766,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-08T22:21:51.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":2050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 6, 2017.  Price not applicable."}],"balance_after":36310,"source":{"system":"sec-edgar","filing":"0001140361-17-024502","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036117024502/doc1.xml","form_type":"4"}},{"id":4297428,"issuer":{"id":6858,"kind":"organization","name":"ACCENDRA HEALTH INC/VA/","symbol":"ACH"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-06-02T15:02:16.000Z","date":"2017-06-01","kind":"tax_withholding","acquired":false,"shares":4941,"price":31.88,"value":157519.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person."}],"balance_after":102880,"source":{"system":"sec-edgar","filing":"0000075252-17-000092","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/75252/000007525217000092/edgar.xml","form_type":"4"}},{"id":4328658,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2017-05-09T17:24:43.000Z","date":"2017-05-05","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the number of stock options outstanding after the transaction from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":17.33,"exercise_date":"2007-12-07","expiration_date":"2017-06-06","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001140361-17-019046","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036117019046/doc1.xml","form_type":"4"}},{"id":4328657,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-09T17:24:43.000Z","date":"2017-05-05","kind":"exercise","acquired":true,"shares":7500,"price":17.33,"value":129975.0,"ownership":{"direct":true},"balance_after":34260,"source":{"system":"sec-edgar","filing":"0001140361-17-019046","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036117019046/doc1.xml","form_type":"4"}},{"id":4456340,"issuer":{"id":6858,"kind":"organization","name":"ACCENDRA HEALTH INC/VA/","symbol":"ACH"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-02-13T17:51:26.000Z","date":"2017-02-09","kind":"grant","acquired":true,"shares":11455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Restricted stock vesting on 2/5/2018"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Balance includes employee stock purchase plan holdings and/or shares acquired through dividend reinvestment transactions not previously reflected in beneficial ownership total."}],"balance_after":107821,"source":{"system":"sec-edgar","filing":"0000075252-17-000024","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/75252/000007525217000024/edgar.xml","form_type":"4"}},{"id":4456339,"issuer":{"id":6858,"kind":"organization","name":"ACCENDRA HEALTH INC/VA/","symbol":"ACH"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-02-13T17:51:26.000Z","date":"2017-02-09","kind":"grant","acquired":true,"shares":9747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted stock with three year vesting date."}],"balance_after":94103,"source":{"system":"sec-edgar","filing":"0000075252-17-000024","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/75252/000007525217000024/edgar.xml","form_type":"4"}},{"id":4456338,"issuer":{"id":6858,"kind":"organization","name":"ACCENDRA HEALTH INC/VA/","symbol":"ACH"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-02-13T17:43:19.000Z","date":"2017-02-06","kind":"tax_withholding","acquired":false,"shares":3823,"price":36,"value":137628.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Correction to beneficial ownership due to administrative error."}],"balance_after":84356,"source":{"system":"sec-edgar","filing":"0000075252-17-000023","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/75252/000007525217000023/edgar.xml","form_type":"4/A","original_submission_date":"2017-02-07"}},{"id":4465623,"issuer":{"id":6858,"kind":"organization","name":"ACCENDRA HEALTH INC/VA/","symbol":"ACH"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-02-07T19:19:37.000Z","date":"2017-02-06","kind":"tax_withholding","acquired":false,"shares":3823,"price":36,"value":137628.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person."}],"balance_after":89297,"source":{"system":"sec-edgar","filing":"0000075252-17-000014","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/75252/000007525217000014/edgar.xml","form_type":"4"}}]}